Abstract:The synthesis and biological characterization of a series of novel leukotriene antagonists and agonists are reported. All of these compounds are derivatives of (5S,6R,7Z)-5-hydroxy-6-mercapto-9-phenyl-7-nonenoic acid. One of the more potent compounds is (5S,6R,7Z)-6-[[(4-carboxy-2-methoxyphenyl)methyl]thio]-5-hydroxy-9 -(4- heptylphenyl)-7-nonenoic acid (3f). In vitro evaluation of this compound on guinea pig trachea revealed that it is a competitive antagonist of LTD4 and LTE4 with pKB values of 6.4 and 5.8, … Show more
“…Another ligand-based method with LTD 4 as template led to success after addressing two problems: the unstable triene moiety had to be replaced by a more stable residue conserving potency, and the CysLT agonistic activity had to be turned to antagonism. On the basis of the nuclear magnetic resonance (NMR) data, leukotriene analogues ( 29 , Scheme ) mimicking the olefinic backbone by a homocinnamyl group were explored. , By variations in the peptide chain, they were turned into antagonists, but only ligands less potent than 24 were obtained . Then, the Merck group started similar investigations yet with decisive changes.…”
Section: Case Study: Medicinal Chemistry Of Cysteinyl
Leukotriene Rec...mentioning
confidence: 99%
“…223,231 By variations in the peptide chain, they were turned into antagonists, but only ligands less potent than 24 were obtained. 232 Then, the Merck group started similar investigations yet with decisive changes. Using an entirely aromatic quinoline derivative (30) instead of homocinnamyl analogue as lead structure and mimetic for the olefinic backbone of LTD 4 , 233 they postulated that attachment of a carboxylic acid or peptide mimetic would further enhance potency (IC 50 = 6 μM).…”
Fatty acids beyond their role as an endogenous energy source and storage are increasingly considered as signaling molecules regulating various physiological effects in metabolism and inflammation. Accordingly, the molecular targets involved in formation and physiological activities of fatty acids hold significant therapeutic potential. A number of these fatty acid targets are addressed by some of the oldest and most widely used drugs such as cyclooxygenase inhibiting NSAIDs, whereas others remain unexploited. Compounds orthosterically binding to proteins that endogenously bind fatty acids are considered as fatty acid mimetics. On the basis of their structural resemblance, fatty acid mimetics constitute a family of bioactive compounds showing specific binding thermodynamics and following similar pharmacokinetic mechanisms. This perspective systematically evaluates targets for fatty acid mimetics, investigates their common structural characteristics, and highlights demands in their discovery and design. In summary, fatty acid mimetics share particularly favorable characteristics justifying the conclusion that their therapeutic potential vastly outweighs the challenges in their design.
“…Another ligand-based method with LTD 4 as template led to success after addressing two problems: the unstable triene moiety had to be replaced by a more stable residue conserving potency, and the CysLT agonistic activity had to be turned to antagonism. On the basis of the nuclear magnetic resonance (NMR) data, leukotriene analogues ( 29 , Scheme ) mimicking the olefinic backbone by a homocinnamyl group were explored. , By variations in the peptide chain, they were turned into antagonists, but only ligands less potent than 24 were obtained . Then, the Merck group started similar investigations yet with decisive changes.…”
Section: Case Study: Medicinal Chemistry Of Cysteinyl
Leukotriene Rec...mentioning
confidence: 99%
“…223,231 By variations in the peptide chain, they were turned into antagonists, but only ligands less potent than 24 were obtained. 232 Then, the Merck group started similar investigations yet with decisive changes. Using an entirely aromatic quinoline derivative (30) instead of homocinnamyl analogue as lead structure and mimetic for the olefinic backbone of LTD 4 , 233 they postulated that attachment of a carboxylic acid or peptide mimetic would further enhance potency (IC 50 = 6 μM).…”
Fatty acids beyond their role as an endogenous energy source and storage are increasingly considered as signaling molecules regulating various physiological effects in metabolism and inflammation. Accordingly, the molecular targets involved in formation and physiological activities of fatty acids hold significant therapeutic potential. A number of these fatty acid targets are addressed by some of the oldest and most widely used drugs such as cyclooxygenase inhibiting NSAIDs, whereas others remain unexploited. Compounds orthosterically binding to proteins that endogenously bind fatty acids are considered as fatty acid mimetics. On the basis of their structural resemblance, fatty acid mimetics constitute a family of bioactive compounds showing specific binding thermodynamics and following similar pharmacokinetic mechanisms. This perspective systematically evaluates targets for fatty acid mimetics, investigates their common structural characteristics, and highlights demands in their discovery and design. In summary, fatty acid mimetics share particularly favorable characteristics justifying the conclusion that their therapeutic potential vastly outweighs the challenges in their design.
“…[8] Since many bioactive compounds such as Montelukast, [9a] Hepatitis Cvirus NS3/4A inhibitors, [9b] and others [9c-e] include a-stereogenic C À Sb onds,t he synthesis of higher-substituted allylic thioethers [10,11] and sulfones [12,13] could be seen as an important synthetic tool in organic chemistry [14,15] and drug synthesis.F urthermore, a-stereogenic allylic Z-configured thioethers showed activity against allergic asthma and other immediate hypersensitivity diseases. [16] Thus we were curious to see whether we could transfer our initial methodology to 1,3-disubstituted allenes.H erein we describe the first rhodium-catalyzed, highly Z-selective and, if desired, asymmetric, hydrothiolation of 1,3-disubstituted allenes.A fter optimization of the reaction conditions using naphthalene-2-thiol and nona-4,5-diene with addition of p-toluenesulfonic acid (PTSA), the sulfone 1 was obtained in 80 %y ield and 91:9 Z selectivity (Table 1). [17][18][19] Furthermore,weinvestigated the scope of different aromatic thiols for this hydrothiolation.…”
A Z-selective rhodium-catalyzed hydrothiolation of 1,3-disubstituted allenes and subsequent oxidation towards the corresponding allylic sulfones is described. Using the bidentate 1,4-bis(diphenylphosphino)butane (dppb) ligand, Z/E-selectivities up to >99:1 were obtained. The highly atom-economic desymmetrization reaction tolerates functionalized aromatic and aliphatic thiols. Additionally, a variety of symmetric internal allenes, as well as unsymmetrically disubstituted substrates were well tolerated, thus resulting in high regioselectivities. Starting from chiral but racemic 1,3-disubstituted allenes a dynamic kinetic resolution (DKR) could be achieved by applying (S,S)-Me-DuPhos as the chiral ligand. The desired Z-allylic sulfones were obtained in high yields and enantioselectivities up to 96 % ee.
“…However, despite the importance of alkyl aminoaryl sulfides, streamlined methods for synthesizing these sulfides have not been fully investigated. Generally, most alkyl aminoaryl sulfides are prepared by a substitution reaction of electrophiles, such as organic halides and/or epoxides, etc., with alkali metal aminoaryl thiolate which is generated from 2-, 3-, and/or 4-aminothiophenol in the presence of strong alkaline bases . Although these classical methods result in good yields, there is limited availability of aminothiophenol derivatives from commercial sources.…”
We have developed two simple and high yielding one-pot syntheses of alkyl aminoaryl sulfides containing a series of four-steps: in situ protection of the free amine by reaction with a Grignard reagent, halogen-lithium exchange, sulfur insertion, and a substitution reaction with various electrophiles. Through this protocol, we have successfully synthesized tert-butyl-2-[4-(2-aminoethyl)phenylsulfanyl]-2-methylpropanoate, a key intermediate for the synthesis of GW7647 and GW9578 (ureido-TiBAs), in 92% yield. Furthermore, we were able to improve the overall yield of GW7647 to 66%, 3 times the yield previously reported.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.